loader
Please Wait
Applying Filters...
menu
    • menu

    Setid F5172788 E1ab 45f9 99fa 878ee42cf91d Applno 202276 Form Tablet Oral Dosage 100mg - Drug Product Composition: Avanafil

    Menu

    Avanafil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,991Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 202276 / DOSAGE - TABLET;ORAL - 100MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    avanafil(UNII: DR5S136IVO)
    (avanafil - UNII:DR5S136IVO)     		avanafil50mg | 100mg | 200mg

    Inactive Ingredients

    Ingredient Name
    Mist Pharmaceuticals, LLC
    Vivus LLC
    VIVUS, Inc.
    calcium carbonate(H0G9379FGK)
    FERRIC OXIDE YELLOW(EX438O2MRT)
    FUMARIC ACID(88XHZ13131)
    hydroxypropyl cellulose (1200000 MW)(RFW2ET671P)  
    HYDROXYPROPYL CELLULOSE, UNSPECIFIED(9XZ8H6N6OH) 
    LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW)(7773C1ROEU)  
    LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED(2165RE0K14)  
    magnesium stearate(70097M6I30)
    MANNITOL(3OWL53L36A)